$XOMA Headlines S&P 500 stages ‘the expected’ break

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$XOMA Headlines

S&P 500 stages ‘the expected’ break to all-time highs 1:04 p.m. Feb. 28, 2014 - Michael Ashbaugh
Restoration Hardware shares fall on co-CEO resigning 7:07 p.m. Dec. 12, 2013 - Wallace Witkowski
3 new bets by a biotech hedge fund 4:56 a.m. July 10, 2012 - The Trading Deck
XOMA wins US rights to market blood pressure drugs 6:56 p.m. Jan. 17, 2012 - MarketWatch.com

Can the Uptrend Continue for XOMA Corp (XOMA)? - Tale of the Tape 37 min ago - Zacks.com
XOMA Corporation (XOMA) Jumps: Stock Rises 6.2% - Tale of the Tape 9:11 a.m. Sept. 5, 2014 - Zacks.com
Increased Earnings Estimates Seen for XOMA Corp (XOMA): Can It Move Higher? - Tale of the Tape 8:55 a.m. Sept. 2, 2014 - Zacks.com
Wedbush Securities' Liana Moussatos On The Art And Science Of Picking Biotechs With Upside 12:01 p.m. Aug. 22, 2014 - Seeking Alpha
5 Red-Hot Biotech Stocks 1:14 a.m. Aug. 19, 2014 - InvestorPlace.com
XOMA's (XOMA) CEO John Varian on Q2 2014 Results - Earnings Call Transcript 10:44 p.m. Aug. 7, 2014 - Seeking Alpha
XOMA (XOMA) Q2 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 7, 2014 - Seeking Alpha
3 Biotech Catalyst Stocks To Own 9:04 a.m. July 31, 2014 - Seeking Alpha
XOMA's CEO Presents at EYEGUARD-B Communication Plan Update Conference (Transcript) 12:46 p.m. July 1, 2014 - Seeking Alpha
2 Attractive, But Speculative Biotechs For Less Than $5 1:04 p.m. June 9, 2014 - Seeking Alpha
Insider Trading Alert - ITMN, WAC And XOMA Traded By Insiders 12:30 p.m. May 16, 2014 - TheStreet.com
XOMA's (XOMA) CEO John Varian Presents at Bank of America Merrill Lynch 2014 Healthcare Conference (Transcript) 12:45 a.m. May 15, 2014 - Seeking Alpha
XOMA Posts Wider Q1 Loss - Analyst Blog 4:00 p.m. May 9, 2014 - Zacks.com
XOMA's (XOMA) CEO John Varian on Q1 2014 Results - Earnings Call Transcript 11:02 p.m. May 7, 2014 - Seeking Alpha
Xoma bounces 2:42 p.m. April 29, 2014 - Seeking Alpha
Why XOMA (XOMA) Stock Is Surging Today 12:35 p.m. April 29, 2014 - TheStreet.com
First Week Of December 20th Options Trading For XOMA 12:45 p.m. April 22, 2014 - TheStreet.com
The Recent Performance of 'Baker Brother Biotech Stocks' is Awful 12:23 p.m. April 15, 2014 - TheStreet.com
Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog 10:50 a.m. March 12, 2014 - Zacks.com
XOMA's CEO Discusses Q4 2013 Results - Earnings Call Transcript 10:39 p.m. March 5, 2014 - Seeking Alpha


Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Global Uveitis Market 2014-2018.pdf 2:38 p.m. Aug. 12, 2014 - PR Newswire - PRF
XOMA Highlights Recent Achievements and Reports Financial Results for Second Quarter 2014 4:02 p.m. Aug. 7, 2014 - GlobeNewswire
XOMA to Present at Two Upcoming Investor Conferences 2:56 p.m. Aug. 6, 2014 - GlobeNewswire
XOMA to Announce Second Quarter 2014 Financial Results and Host Webcast on August 7 1:16 p.m. July 30, 2014 - GlobeNewswire
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
XOMA Call Today at 4:30pm ET/1:30pm PT to Confirm Communication Plan for EYEGUARD(TM)-B Clinical Program 4:02 p.m. June 30, 2014 - GlobeNewswire
Health Care Sector Stocks Highlight -- Research on XOMA, Novartis, Catamaran, and Castlight Health 5:20 a.m. June 2, 2014 - PR Newswire - PRF
XOMA to Present at the Jefferies Global Healthcare Conference 3:01 p.m. May 28, 2014 - GlobeNewswire
XOMA to Present at the Bank of America Merrill Lynch Health Care Conference 3:31 p.m. May 12, 2014 - GlobeNewswire
XOMA Reports First Quarter 2014 Operational Highlights and Financial Results 4:03 p.m. May 7, 2014 - GlobeNewswire
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on XOMA, ServiceNow, Ctrip.com, and Splunk 4:26 a.m. May 1, 2014 - PR Newswire - PRF
XOMA to Announce First Quarter 2014 Financial Results and Host Webcast on May 7 1:26 p.m. April 30, 2014 - GlobeNewswire
XOMA Finalizes Plans for Gevokizumab Phase 3 Clinical Program in Pyoderma Gangrenosum 9:01 a.m. April 28, 2014 - GlobeNewswire
Healthcare Companies Report Financial Results, Partnerships, and Recognitions - Analyst Notes on Keryx, WellCare, Zogenix, Orexigen Therapeutics, and XOMA 8:00 a.m. March 19, 2014 - PR Newswire - PRF
Technical Roundup - Most Active: J. C. Penney, XOMA, BlackBerry and Nokia 1:22 p.m. March 6, 2014 - PR Newswire - PRF
XOMA Reports 2013 Operational Highlights and Fourth Quarter and Full-Year 2013 Financial Results 5:58 p.m. March 4, 2014 - GlobeNewswire
XOMA Provides Update on Gevokizumab Proof-of-Concept Program 5:37 p.m. March 4, 2014 - GlobeNewswire
XOMA Receives Orphan Drug Designation From U.S. FDA for Pyoderma Gangrenosum 7:21 p.m. Feb. 24, 2014 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GreenCore AI Agents Shatter Monthly Record in Ops Surge

Updated Category News Views 6

Dispatch from the Digital Trenches GreenCore Solutions Corp. (GSC) just made a bit of a splash with those numbers any company would salivate over. We're talking 24.5 million AI agent transactions in just one month. If that doesn't jolt your morning coffee, not sure what will. AI Agents Getting Busy For those out of the loop, GSC isn't your run-of-the-mill tech outfit....

Continue Reading
VEVOR's Labor Day Salute to Home DIY Warriors

Updated Category News Views 0

Celebrating the DIY Spirit When most folks think of Labor Day, they picture grilling and lounging. But there's a whole crew out there wielding hammers and paintbrushes, making the most of their long weekend. That's right, Labor Day isn't just rest for some; it's a roll-up-your-sleeves and get it done kind of holiday, and VEVOR is tipping its hat to those folks. Home...

Continue Reading
Freeport-McMoRan Hit with Legal Probe: What's Next?

Updated Category News Views 4

Investigating the Movers and Shakers at Freeport When legal hawks like Kahn Swick & Foti, LLC sink their teeth into something, you can bet it's not just to nibble. These folks have jumped headfirst into probing Freeport-McMoRan Inc. (NYSE:FCX), ready to dismantle any smoke screens that might have been thrown up after the unfortunate Grasberg Block Cave mine incident. The...

Continue Reading
Hyundai's Revolutionary US Steel Mill Set for 2029 Rollout

Updated Category News Views 2

Hyundai's Major Steel Move: A Multibillion-Dollar Stake The steel industry scene in the U.S. just got a lot hotter with Hyundai's announcement of a $5.8 billion Electric Arc Furnace-based integrated steel mill in Louisiana. This game-changing project isn’t just a headline; it’s a concrete step towards beefing up the U.S. manufacturing backbone. Talk about...

Continue Reading
Shenzhen Media Push: Shaping Asia-Pacific's Future

Updated Category News Views 0

A Metamorphosis in Shenzhen You ever hear about a place that rockets from obscurity to global significance in the blink of an eye? Well, Shenzhen, China is that place. Forty years ago, it was just a quaint fishing village. Fast forward a few decades, and you've got yourself an international powerhouse—a testament to China's rapid development strategy. Shenzhen is now...

Continue Reading
Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 4

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Frederick’s Heartbeat: 2026 Sass LOCAL Issue Drops

Updated Category News Views 0

Frederick’s Local Scene Takes the Spotlight Ever strolled down a street and felt the neighborhood pulse through your bones? That vibe—you know it if you've been to Frederick, Maryland. And that very essence is captured in the latest edition of Sass Magazine's LOCAL issue. This isn't just your garden-variety publication; it's a window into the heart of Frederick...

Continue Reading
Delisting Gray Wolf Sparks Heated Hunter Nation Debate

Updated Category News Views 2

Unraveling the Gray Wolf Controversy What are we looking at here—political maneuvering wrapped in a fur coat? Trump's executive order is making some calls I didn’t see coming. By pushing to delist the gray wolf from the Endangered Species Act (ESA), he's stirring up a mix of joy, outrage, and a boatload of debate about environmental ethics, conservation priorities,...

Continue Reading
Planes Moving Seizing Growth in Cincinnati-Dayton Corridor

Updated Category News Views 4

Strategic Movements in the Logistics Arena Putting wheels to brilliant moves, Planes Moving & Storage of Dayton is tweaking its operations with a big change in scenery—expect the dynamics in the Cincinnati-Dayton corridor to really start popping. Now, if you’ve ever skimmed the logistics world, you know it’s a place where shuffles can be seismic, and relocating...

Continue Reading
Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading

Top 5 Most Recently Viewed Articles

Novo Nordisk Faces Challenges Amid Changing Market Dynamics

Updated Category News Views 226

Recent Sales Performance Novo Nordisk A/S (NVO) has recently reported substantial sales for the second quarter, totaling approximately $11.68 billion, slightly below market expectations of $11.79 billion. While this represents a year-over-year growth of 13% in Danish kroner, the results indicate the company is facing headwinds in the competitive pharmaceutical landscape....

Continue Reading
Rathbones Group's Strategic Position in Urban Logistics REIT

Updated Category News Views 129

Understanding the Disclosure by Rathbones Group Plc The recent public disclosure from Rathbones Group Plc reveals critical information regarding its strategic position within the Urban Logistics REIT landscape. This step showcases how influential players in the market operate, especially when holding a 1% or more stake in relevant securities. Key Details of the Disclosure...

Continue Reading
Mauro Gregorio Joins Radius Recycling Board for Strategic Growth

Updated Category News Views 118

Mauro Gregorio Appointed to Radius Recycling's Board Radius Recycling, Inc. (NASDAQ: RDUS), a prominent manufacturer of recycled metal products in North America, has recently made a significant addition to its Board of Directors with the appointment of Mauro Gregorio as an independent director. Set to begin his term soon, Gregorio is expected to bring a wealth of...

Continue Reading
Tongji University's Remarkable Rise in Global Management Rankings

Updated Category News Views 117

A Breakthrough Achievement for Tongji SEM Recently, Tongji University School of Economics and Management (Tongji SEM) celebrated an incredible milestone by ranking 8th globally in the Financial Times 2025 Global Master in Management Ranking. This marks a significant leap for Tongji SEM, as it has consistently performed well in the educational sector, achieving a spot...

Continue Reading
IBM's Strong Q2 Performance Sparks Analyst Confidence

Updated Category News Views 152

IBM Reports Strong Q2 Performance International Business Machines (IBM) has showcased impressive results for its fiscal second quarter, surpassing Wall Street expectations in multiple key performance metrics. Despite this strong showing, the stock experienced a downturn post-announcement, raising eyebrows among investors. AI and Hybrid Cloud: The Driving Forces In an age...

Continue Reading